Cargando…

Hepatocellular Carcinoma Is a Natural Target for Adeno-Associated Virus (AAV) 2 Vectors

SIMPLE SUMMARY: Gene therapy is a novel approach to treat diseases by introducing corrective genetic information into target cells. Adeno-associated virus vectors are the most frequently applied gene delivery tools for in vivo gene therapy and are also studied as part of innovative anticancer strate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Meumann, Nadja, Schmithals, Christian, Elenschneider, Leroy, Hansen, Tanja, Balakrishnan, Asha, Hu, Qingluan, Hook, Sebastian, Schmitz, Jessica, Bräsen, Jan Hinrich, Franke, Ann-Christin, Olarewaju, Olaniyi, Brandenberger, Christina, Talbot, Steven R., Fangmann, Josef, Hacker, Ulrich T., Odenthal, Margarete, Ott, Michael, Piiper, Albrecht, Büning, Hildegard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8774135/ https://www.ncbi.nlm.nih.gov/pubmed/35053588 http://dx.doi.org/10.3390/cancers14020427

Ejemplares similares

Adeno‐associated virus serotype 2 capsid variants for improved liver‐directed gene therapy
por: Meumann, Nadja, et al.
Publicado: (2023)

Towards Clinical Implementation of Adeno-Associated Virus (AAV) Vectors for Cancer Gene Therapy: Current Status and Future Perspectives
por: Hacker, Ulrich T., et al.
Publicado: (2020)

Vector uncoating limits adeno-associated viral vector-mediated transduction of human dendritic cells and vector immunogenicity
por: Rossi, Axel, et al.
Publicado: (2019)

Adeno-Associated Viral Vectors at the Frontier between Tolerance and Immunity
por: Mingozzi, Federico, et al.
Publicado: (2015)

Adeno-associated virus type 2 (AAV2) uncoating is a stepwise process and is linked to structural reorganization of the nucleolus
por: Sutter, Sereina O., et al.
Publicado: (2022)

Capsid Modifications for Targeting and Improving the Efficacy of AAV Vectors
por: Büning, Hildegard, et al.
Publicado: (2019)

Enhancing the Clinical Potential of AAV Vectors by Capsid Engineering to Evade Pre-Existing Immunity
por: Bartel, Melissa, et al.
Publicado: (2011)

Immunogenicity of Novel AAV Capsids for Retinal Gene Therapy
por: Gehrke, Miranda, et al.
Publicado: (2022)

Modifying immune responses to adeno-associated virus vectors by capsid engineering
por: Bentler, Martin, et al.
Publicado: (2023)

Improved adeno-associated virus (AAV) serotype 1 and 5 vectors for gene therapy
por: Sen, Dwaipayan, et al.
Publicado: (2013)

Novel AAV capsids for intravitreal gene therapy of photoreceptor disorders
por: Pavlou, Marina, et al.
Publicado: (2021)

Adeno-Associated Virus (AAV) Versus Immune Response
por: Rabinowitz, Joseph, et al.
Publicado: (2019)

Adeno-associated Virus (AAV) Serotypes Have Distinctive Interactions with Domains of the Cellular AAV Receptor
por: Pillay, Sirika, et al.
Publicado: (2017)

Adeno-Associated Virus (AAV) as a Vector for Gene Therapy
por: Naso, Michael F., et al.
Publicado: (2017)

Human Immune Responses to Adeno-Associated Virus (AAV) Vectors
por: Ronzitti, Giuseppe, et al.
Publicado: (2020)

Adeno‐associated virus (AAV)-based gene therapy for glioblastoma
por: Xu, Xin, et al.
Publicado: (2021)

DNA Minicircle Technology Improves Purity of Adeno-associated Viral Vector Preparations
por: Schnödt, Maria, et al.
Publicado: (2016)

Autophagy determines efficiency of liver‐directed gene therapy with adeno‐associated viral vectors
por: Hösel, Marianna, et al.
Publicado: (2017)

Methylation Status of the Adeno-Associated Virus Type 2 (AAV2)
por: Tóth, Renáta, et al.
Publicado: (2019)

Immunogenicity of Recombinant Adeno-Associated Virus (AAV) Vectors for Gene Transfer
por: Arjomandnejad, Motahareh, et al.
Publicado: (2023)

Adeno-Associated Virus Receptor-Binding: Flexible Domains and Alternative Conformations through Cryo-Electron Tomography of Adeno-Associated Virus 2 (AAV2) and AAV5 Complexes
por: Hu, Guiqing, et al.
Publicado: (2022)

Novel Mutant AAV2 Rep Proteins Support AAV2 Replication without Blocking HSV-1 Helpervirus Replication
por: Seyffert, Michael, et al.
Publicado: (2017)

GluA4-Targeted AAV Vectors Deliver Genes Selectively to Interneurons while Relying on the AAV Receptor for Entry
por: Hartmann, Jessica, et al.
Publicado: (2019)

Ex Vivo/In vivo Gene Editing in Hepatocytes Using “All-in-One” CRISPR-Adeno-Associated Virus Vectors with a Self-Linearizing Repair Template
por: Krooss, Simon Alexander, et al.
Publicado: (2019)

Pre-Clinical Assessment of Immune Responses to Adeno-Associated Virus (AAV) Vectors
por: Basner-Tschakarjan, Etiena, et al.
Publicado: (2014)

Creating an arsenal of Adeno-associated virus (AAV) gene delivery stealth vehicles
por: Smith, J. Kennon, et al.
Publicado: (2018)

Molecular design for recombinant adeno-associated virus (rAAV) vector production
por: Aponte-Ubillus, Juan Jose, et al.
Publicado: (2017)

Proteomic Landscape of Adeno-Associated Virus (AAV)-Producing HEK293 Cells
por: Strasser, Lisa, et al.
Publicado: (2021)

A multiplexed barcode approach to simultaneously evaluate gene delivery by adeno-associated virus capsid variants in nonhuman primates
por: Stone, Daniel, et al.
Publicado: (2023)

Hydroxylation of N-acetylneuraminic Acid Influences the in vivo Tropism of N-linked Sialic Acid-Binding Adeno-Associated Viruses AAV1, AAV5, and AAV6
por: Lopez-Gordo, Estrella, et al.
Publicado: (2021)

Adeno-Associated Viruses (AAV) and Host Immunity – A Race Between the Hare and the Hedgehog
por: Rapti, Kleopatra, et al.
Publicado: (2021)

Therapeutic Applications of Adeno-Associated Virus (AAV) Gene Transfer of HLA-G in the Eye
por: Gilger, Brian C., et al.
Publicado: (2022)

Rapid characterization of adeno-associated virus (AAV) gene therapy vectors by mass photometry
por: Wu, Di, et al.
Publicado: (2022)

Adeno-Associated Virus (AAV) - Based Gene Therapies for Retinal Diseases: Where are We?
por: Ail, Divya, et al.
Publicado: (2023)

Gene therapy of adeno‐associated virus (AAV) vectors in preclinical models of ischemic stroke
por: Wang, Jing, et al.
Publicado: (2023)

Pyroptotic and Necroptotic Cell Death in the Tumor Microenvironment and Their Potential to Stimulate Anti-Tumor Immune Responses
por: Scarpitta, Allan, et al.
Publicado: (2021)

Optimization of the Capsid of Recombinant Adeno-Associated Virus 2 (AAV2) Vectors: The Final Threshold?
por: Aslanidi, George V., et al.
Publicado: (2013)

The X Gene of Adeno-Associated Virus 2 (AAV2) Is Involved in Viral DNA Replication
por: Cao, Maohua, et al.
Publicado: (2014)

 Adeno-associated Virus (AAV) Dual Vector Strategies for Gene Therapy Encoding Large Transgenes
por: McClements, Michelle E., et al.
Publicado: (2017)

Adeno-Associated Virus (AAV-DJ)—Cryo-EM Structure at 1.56 Å Resolution
por: Xie, Qing, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_qn6ce8n6p1dbuqoi5rv9r603ct